CNBC January 29, 2024
Key Points
– Elon Musk’s neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is “recovering well,” according to a post on X.
– Neuralink began recruiting patients for its first in-human clinical trial in the fall after it received approval from the FDA to conduct the study back in May.
– The in-human clinical trial marks just one step in Neuralink’s path toward commercialization.
Elon Musk‘s neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is “recovering well,” the billionaire said in a post on X, formerly known as Twitter, on Monday.
The company is developing a brain implant that aims...
Today's Sponsors
Today's Sponsor